Anesthetic treatment of patients with osteogenesis imperfecta

被引:1
作者
Engel Espinosa, W. [1 ]
Arrazola Cabrera, B. [1 ]
Peralta Rodriguez, P. [1 ]
Fernandez Izquierdo, M. C. [1 ]
Garcia Molina, C. [1 ]
Ortigosa Solorzano, E. [1 ]
机构
[1] Hosp Univ Getafe, Serv Anestesiol & Reanimac, Carretera Toledo,Km 12 500, Getafe 28905, Madrid, Spain
来源
REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION | 2011年 / 58卷 / 03期
关键词
Osteogenesis imperfecta; Systemic comorbidity; Bisphosphonates; Airway management; Hyperthermia; Hemorrhagic diathesis; Postoperative pain;
D O I
10.1016/S0034-9356(11)70022-6
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and objective: Although the prevalence of osteogenesis imperfecta is low, the effect of this hereditary disease on patients' quality of life is considerable. We report our experience in the perioperative management of patients with this condition in our hospital. Patients and methods: Retrospective study describing the interventions on patients with this disease in our hospital from 1991 to 2009. We analyzed demographic data, disease variants, concomitant disorders, surgical procedures, type of anesthesia, and intraoperative and postoperative complications. Results: From 1991 to 2009, 105 procedures were performed on 29 patients (ages 1 to 25 years) with osteogenesis imperfecta (37.9% women and 62.1% men). The most common type of osteogenesis imperfecta was type III (65.5%). Most patients (93%) had no associated diseases. Two patients were allergic to latex. No complications occurred in 62% of interventions. Reported complications during surgery were 1 case of non-malignant hypertherrnia and 1 contralateral femur fracture. Conclusions: The prevalence of osteogenesis imperfecta is low. Treatment requires a multidisciplinary approach, in which appropriate perioperative management must be based on a proper understanding of the skeletal and extraskeletal abnormalities associated with this disease.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 16 条
[1]   Early bisphosphonate treatment in infants with severe osteogenesis imperfecta [J].
Antoniazzi, Franco ;
Zamboni, Giorgio ;
Lauriola, Silvana ;
Donadi, Luisa ;
Adami, Silvano ;
Tato, Luciano .
JOURNAL OF PEDIATRICS, 2006, 149 (02) :174-179
[2]   Cardiac abnormalities in osteogenesis imperfecta. Case-control echocardiographic study [J].
Bonilla Jimenez, Vanesa ;
Saavedra Falero, Jesus ;
Alberca Vela, Maria Teresa ;
Diaz Guardiola, Patricia ;
Iglesias Bolano, Paloma ;
Pavon, Isabel .
MEDICINA CLINICA, 2010, 135 (15) :681-684
[3]   RADIOLOGICAL MANIFESTATIONS OF BISPHOSPHONATE TREATMENT WITH APD IN A CHILD SUFFERING FROM OSTEOGENESIS IMPERFECTA [J].
DEVOGELAER, JP ;
MALGHEM, J ;
MALDAGUE, B ;
DEDEUXCHAISNES, CN .
SKELETAL RADIOLOGY, 1987, 16 (05) :360-363
[4]   An unusual manifestation of bleeding diathesis in a patient with osteogenesis imperfecta [J].
Edge, G ;
Okafor, B ;
Fennelly, ME ;
Ransford, AO .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1997, 14 (02) :215-219
[5]   Bisphosphonates: Mechanisms of action [J].
Fleisch, H .
ENDOCRINE REVIEWS, 1998, 19 (01) :80-100
[6]   Increased postoperative febrile response in children with osteogenesis imperfecta [J].
Ghert, M ;
Allen, B ;
Davids, J ;
Stasikelis, P ;
Nicholas, D .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2003, 23 (02) :261-264
[7]   Cyclic administration of pamidronate in children with severe osteogenesis imperfecta [J].
Glorieux, FH ;
Bishop, NJ ;
Plotkin, H ;
Chabot, G ;
Lanoue, G ;
Travers, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :947-952
[8]  
Hall RMO., 1992, PAEDIATRIC ANAESTHES, V2, P115
[9]   CARDIOVASCULAR INVOLVEMENT IN OSTEOGENESIS IMPERFECTA [J].
HORTOP, J ;
TSIPOURAS, P ;
HANLEY, JA ;
MARON, BJ ;
SHAPIRO, JR .
CIRCULATION, 1986, 73 (01) :54-61
[10]  
Isotalo PA, 1999, CAN J CARDIOL, V15, P1139